Alza Delivery Technologies Reduce Drug Enhancement Costs To $80 Mil.
Executive Summary
Alza drug delivery technologies reduce the cost of developing an enhanced version of an already-marketed drug to $70 mil.-$80 mil., Alza Chairman Sam Saks, MD, said during Johnson & Johnson's business review Sept. 23